MEDVi holds its refill rate constant through dose escalation—$299/month semaglutide, $399/month tirzepatide at every dose. This evidence-based guide compares MEDVi's dose-agnostic pricing to PlexusDx's identical policy, normalizes first-month versus refill costs over twelve months, and shows where.

Fridays Health publishes plan-tier pricing but does not document whether your monthly rate changes when your clinician increases your semaglutide or tirzepatide dose. PlexusDx guarantees the same price at every dose.